_version_ 1797285436775727104
author Hermann Einsele
Javier Briones
Fabio Ciceri
Irene García Cadenas
Fred Falkenburg
Natacha Bolaños
H.M. Mirjam Heemskerk
Roch Houot
Michael Hudecek
Franco Locatelli
Kate Morgan
Emma C. Morris
Michael O’Dwyer
Jordi Gil Sierra
Marcel van den Brink
Arjan A. van de Loosdrecht
author_facet Hermann Einsele
Javier Briones
Fabio Ciceri
Irene García Cadenas
Fred Falkenburg
Natacha Bolaños
H.M. Mirjam Heemskerk
Roch Houot
Michael Hudecek
Franco Locatelli
Kate Morgan
Emma C. Morris
Michael O’Dwyer
Jordi Gil Sierra
Marcel van den Brink
Arjan A. van de Loosdrecht
author_sort Hermann Einsele
collection DOAJ
first_indexed 2024-03-07T18:02:10Z
format Article
id doaj.art-f7bde4df68684867baf82fb55cc1d6b8
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T18:02:10Z
publishDate 2021-10-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-f7bde4df68684867baf82fb55cc1d6b82024-03-02T10:31:07ZengWileyHemaSphere2572-92412021-10-01510e64210.1097/HS9.0000000000000642202110000-00005The EHA Research Roadmap: Immune-based Therapies for Hematological MalignanciesHermann Einsele0Javier Briones1Fabio Ciceri2Irene García Cadenas3Fred Falkenburg4Natacha Bolaños5H.M. Mirjam Heemskerk6Roch Houot7Michael Hudecek8Franco Locatelli9Kate Morgan10Emma C. Morris11Michael O’Dwyer12Jordi Gil Sierra13Marcel van den Brink14Arjan A. van de Loosdrecht151 Department of Internal Medicine II, University Hospital Würzburg, Germany2 Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain3 Department Hematology and BMT Unit, San Raffaele Scientific Institute, Milano, Italy2 Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain4 Department of Hematology, Leiden University Medical Center, The Netherlands5 Lymphoma Coalition Europe, Paris, France4 Department of Hematology, Leiden University Medical Center, The Netherlands6 CHU Rennes, University of Rennes, INSERM U1236, France1 Department of Internal Medicine II, University Hospital Würzburg, Germany7 La Sapienza, University of Rome, Italy9 Myeloma Patients Europe, Brussels, Belgium10 University College London, United Kingdom11 National University of Ireland, Galway, Ireland2 Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain12 Memorial Sloan-Kettering Cancer Center and Sloan Kettering Institute, New York, NY, USA14 Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, The Netherlandshttp://journals.lww.com/10.1097/HS9.0000000000000642
spellingShingle Hermann Einsele
Javier Briones
Fabio Ciceri
Irene García Cadenas
Fred Falkenburg
Natacha Bolaños
H.M. Mirjam Heemskerk
Roch Houot
Michael Hudecek
Franco Locatelli
Kate Morgan
Emma C. Morris
Michael O’Dwyer
Jordi Gil Sierra
Marcel van den Brink
Arjan A. van de Loosdrecht
The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
HemaSphere
title The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
title_full The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
title_fullStr The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
title_full_unstemmed The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
title_short The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
title_sort eha research roadmap immune based therapies for hematological malignancies
url http://journals.lww.com/10.1097/HS9.0000000000000642
work_keys_str_mv AT hermanneinsele theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT javierbriones theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT fabiociceri theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT irenegarciacadenas theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT fredfalkenburg theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT natachabolanos theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT hmmirjamheemskerk theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT rochhouot theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT michaelhudecek theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT francolocatelli theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT katemorgan theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT emmacmorris theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT michaelodwyer theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT jordigilsierra theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT marcelvandenbrink theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT arjanavandeloosdrecht theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT hermanneinsele eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT javierbriones eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT fabiociceri eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT irenegarciacadenas eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT fredfalkenburg eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT natachabolanos eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT hmmirjamheemskerk eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT rochhouot eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT michaelhudecek eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT francolocatelli eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT katemorgan eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT emmacmorris eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT michaelodwyer eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT jordigilsierra eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT marcelvandenbrink eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies
AT arjanavandeloosdrecht eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies